Peptide index

Apex Peptide Index™

TB-500

Synthetic thymosin beta-4–related peptideTISSUE & REGENERATIVELEVEL 02 · Preclinical research

Overview

TB-500 is described as a synthetic peptide related to thymosin beta-4, with proposed applications in tissue-repair research. Claims about recovery benefits require caution because the supplied guide does not establish clinical efficacy or clearly distinguish evidence for TB-500 from evidence for thymosin beta-4.

0/3 selected

Biological background

Thymosin beta-4 is a naturally occurring peptide distributed across many tissues and associated with actin biology, cellular movement, and repair processes. The guide presents TB-500 as an engineered derivative intended to reproduce these activities, but does not specify its molecular identity or substantiate claims of enhanced activity.

Mechanism

The guide links TB-500 to actin-associated processes that influence cellular movement during tissue repair. It also proposes effects on new blood vessel formation and inflammatory signaling. Whether these mechanisms have been demonstrated for the specific compound called TB-500, rather than inferred from thymosin beta-4 research, remains unclear.

Actin
  1. 01

    Molecular target

  2. 02

    Cellular signal

  3. 03

    Biological process

Research areas

Wound RepairMusculoskeletal RecoveryVascular RemodelingInflammatory RegulationNeural Repair

Evidence

LEVEL 02 · Preclinical research

Laboratory or animal research exists. Findings do not transfer reliably to people.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

What the source states

The source guide portrays TB-500 as a candidate for repairing damaged tissues and supporting recovery after injury. It extends these proposed applications to muscles, joints, and neurological function without supplying supporting studies in the extracted material. The source also characterizes tolerability favorably and raises a concern about tumor biology in connection with blood vessel formation.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

What remains uncertain

The compound's precise identity, the extent of TB-500-specific research, and its effects in humans cannot be established from these notes. Proposed benefits should not be treated as demonstrated clinical outcomes.

Safety information

Safety data are limited, and the guide's favorable tolerability claims are not substantiated by the supplied material. It mentions fatigue and dizziness and raises a potential concern about effects on tumor-associated vascular growth, but the frequency and clinical significance of these risks remain uncertain. This information is educational and is not medical advice.

Regulatory context

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

References

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

  • TB-500 peptide for healing injuries
  • TB-500 muscle and tendon recovery
  • TB-500 peptide in soft tissue repair

Editorial record

Editorial status
source reviewed
Last updated
2026-09-14
Last reviewed
2026-09-13
Language
EN

Flagged for editorial review

  • · Exact molecular identity unspecified
  • · TB-500 and thymosin beta-4 evidence may be conflated
  • · Enhanced regenerative activity claim unsupported
  • · Human tolerability claims lack supporting evidence
  • · Preclinical evidence rating provisional

Disclaimer

APEX PHARMA 360® provides scientific and educational information for informational purposes only. The information presented on this platform is not intended to diagnose, treat, cure or prevent any disease and does not constitute medical advice, medical treatment or a recommendation to use any particular substance or compound. Scientific research and regulatory status can change over time and may differ between jurisdictions. Experimental or research-stage compounds should not be interpreted as approved medicines. Always consult an appropriately qualified healthcare professional for individual medical questions and verify applicable laws and regulatory requirements in your jurisdiction.